Comparison Between Bupivacaine-Dexmedetomidine Versus Bupivacaine-Dexamethasone in Pericapsular Nerve Group (PENG) Block
Phase 1
Recruiting
- Conditions
- Hip FracturesPost Operative Pain
- Interventions
- Drug: Pericapsular Nerve Group (PENG) Block
- Registration Number
- NCT06294665
- Lead Sponsor
- Ain Shams University
- Brief Summary
The aim of this work is to compare the effectiveness of bupivacaine- dexmedetomidine mixture versus bupivacaine-dexamethasone mixture in PENG Block as Post-operative Analgesia in Hip surgeries
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Age 18-65 years.
- Sex: Both sexes.
- American Society of Anaesthesiologists (ASA) Physical Status Class I and II.
- Scheduled for hip surgeries under spinal anaesthesia.
Exclusion Criteria
- Declining to give written informed consent.
- History of allergy to the medications used in the study.
- Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
- Psychiatric disorder.
- American Society of Anesthesiologists (ASA) Physical Status Class III and IV.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group A : ( Bupivacaine + Dexmedetomidine ) Pericapsular Nerve Group (PENG) Block Group A : will receive bupivacaine 0.25% + dexmedetomidine 1 mic/kg, total volume (20 ml) Group B: ( Bupivacaine + Dexamethasone ) Pericapsular Nerve Group (PENG) Block Group B : will receive bupivacaine 0.25% +dexamethasone (8 mg), total volume(20 ml).
- Primary Outcome Measures
Name Time Method The time to the first request of analgesia 9 months The time interval between the onset of the local infiltration done at the end of the operation and the first request to postoperative analgesia.
- Secondary Outcome Measures
Name Time Method Total doses of analgesia (Nalbuphine) given to patients in 24 hours postoperatively 9 months Occurrence of side effects of drugs. 9 months
Trial Locations
- Locations (1)
Ain Shams University
🇪🇬Cairo, Egypt
Ain Shams University🇪🇬Cairo, EgyptFatma EbeidContact+201095569596dr.fatma_ebeid@yahoo.comMohamed SalamaPrincipal Investigator